Olympiad Research’s Adient ADNT Stock Holding History

Olympiad Research’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,870	Closed	-$468K	–	352
2023 Q4	$468K	Buy	12,870 +3,809	+42%	+$131K	0.37%	69
2023 Q3	$333K	Buy	+9,061	New	+$361K	0.33%	98

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Olympiad Research's ADNT Position: Q1 2024 in Review

Olympiad Research sold out of Adient (ADNT) in Q1 2024, closing a stake of 12,870 shares — an estimated $468K sold.

Olympiad Research first reported a position in ADNT in Q3 2023 and held it in 2 quarters. The position peaked at $468K in Q4 2023. 311 funds tracked by Wall St. Rank hold ADNT as of Q1 2024.

Olympiad Research reported no remaining Adient position as of Q1 2024 after selling out during the quarter.
Olympiad Research sold 12,870 Adient shares in Q1 2024, an estimated $468K.
Olympiad Research first reported a position in Adient in Q3 2023 and held it in 2 quarters.
Olympiad Research's Adient position peaked at $468K in Q4 2023.
311 funds tracked by Wall St. Rank held Adient as of Q1 2024.

Based on Olympiad Research's 13F filing for Q1 2024, filed 13 May 2024.